What are the best birth control options for a 37-year-old woman with poorly controlled hypertension, depression, anxiety, obesity (Body Mass Index (BMI) over 40), a smoking history, and a history of headaches (not migraines)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraception Recommendations for 37-Year-Old with Multiple Cardiovascular Risk Factors

This patient should use progestin-only contraceptives (pills, implants, or IUDs) or non-hormonal methods (copper IUD, barrier methods), while combined hormonal contraceptives are absolutely contraindicated due to her poorly controlled hypertension, smoking history, obesity, and age. 1, 2

Why Combined Hormonal Contraceptives Are Contraindicated

Combined oral contraceptives, patches, and vaginal rings are Category 4 (unacceptable health risk) for this patient due to her poorly controlled hypertension, making them absolutely contraindicated. 1

  • Women with systolic BP ≥160 or diastolic ≥100 mmHg have a Category 4 contraindication to combined hormonal methods. 1
  • The combination of poorly controlled hypertension, age >35 years, smoking history, and obesity (BMI >40) creates a 6.1-68.1 times higher risk of myocardial infarction compared to women without these risk factors. 2
  • Risk of ischemic stroke increases 8-15 fold in hypertensive women using combined oral contraceptives versus women without either risk factor. 2
  • Combined hormonal contraceptives should be avoided even in women with adequately controlled hypertension (Category 3), and this patient's hypertension is poorly controlled. 1

Recommended Contraceptive Options

First-Line: Progestin-Only Methods

Progestin-only contraceptives are Category 1-2 (safe to use) for women with hypertension and carry substantially less cardiovascular risk than combined methods. 1, 2, 3

Progestin-only pills (norethindrone):

  • Category 2 (advantages generally outweigh risks) for women with poorly controlled hypertension. 1
  • No significant association with elevated blood pressure in studies following women for 2-3 years. 4
  • Must be taken at the same time every day; backup contraception needed if taken >3 hours late. 5
  • Depression and anxiety are not contraindications (Category 1). 1
  • Obesity (BMI >40) is Category 1 for progestin-only pills. 1

Etonogestrel implant (Nexplanon):

  • Category 2 for women with poorly controlled hypertension. 1
  • Highly effective (>99%) with no daily adherence requirements. 6
  • Category 1 for obesity, depression, and anxiety. 1
  • Lasts 3 years with rapid return to fertility after removal. 5

Levonorgestrel IUD:

  • Category 2 for women with poorly controlled hypertension. 1
  • Highly effective with minimal systemic hormone absorption. 1
  • Category 1 for obesity, depression, anxiety, and non-migrainous headaches. 1

Second-Line: Non-Hormonal Methods

Copper IUD:

  • Category 1 (no restrictions) for all of this patient's conditions including poorly controlled hypertension, obesity, smoking, depression, and headaches. 1
  • Highly effective (>99%) with no hormonal effects on blood pressure or cardiovascular risk. 1
  • Lasts up to 10 years. 1

Barrier methods (condoms, diaphragm):

  • No medical contraindications but lower typical-use effectiveness (82-88%). 1
  • Should be considered if patient prefers non-hormonal, non-invasive option. 1

Critical Management Steps

Before Initiating Any Contraceptive Method

Blood pressure must be properly measured and documented on at least two separate occasions to confirm severity. 1

  • Measure BP in both arms; differences >20 mmHg systolic or >10 mmHg diastolic require vascular evaluation. 1
  • Assess for other cardiovascular risk factors: smoking status (current vs. former), duration of hypertension, family history of early cardiovascular disease. 1, 7
  • Rule out secondary causes of hypertension given poor control: renal disease, sleep apnea (especially with obesity and headaches), medication effects. 1

Hypertension Management Takes Priority

This patient's poorly controlled hypertension must be addressed urgently before or concurrent with contraceptive initiation. 1

  • Discontinue any substances that impair BP control: NSAIDs, decongestants, excessive caffeine (>300 mg/day), herbal supplements (Ma Huang, St. John's Wort). 1
  • Initiate or intensify antihypertensive therapy with goal BP <130/80 mmHg. 1
  • If currently on combined hormonal contraceptives, discontinue immediately as they increase plasma renin substrate and activate the renin-angiotensin-aldosterone system, worsening hypertension. 2, 8

Ongoing Monitoring Requirements

Blood pressure must be checked at least every 6 months for any woman using hormonal contraceptives, and more frequently (every 1-2 months) until hypertension is controlled. 2, 6

  • Women who have BP measured before contraceptive use have 2-2.5 fold decreased risk of myocardial infarction and ischemic stroke. 3
  • Monitor for irregular bleeding patterns with progestin-only methods, which are common but not dangerous. 5
  • Evaluate any new severe or persistent headaches, as this requires discontinuation and evaluation. 5

Addressing Specific Patient Factors

Smoking History

  • If currently smoking: strongly advise cessation as smoking combined with any hormonal contraceptive increases cardiovascular risk. 5, 3
  • Current smokers >35 years using combined hormonal contraceptives have 10-fold increased risk of myocardial infarction. 3
  • Progestin-only methods remain safer options even for current smokers. 1, 3

Obesity (BMI >40)

  • Obesity alone is Category 2 for combined methods, but combined with other risk factors makes them Category 4. 1
  • Progestin-only pills, implants, and both IUDs are Category 1 for obesity. 1
  • Weight should be monitored as oral contraceptives can cause fluid retention. 8

Depression and Anxiety

  • All contraceptive methods are Category 1 for depressive disorders. 1
  • Very rarely, progestin-only methods have been associated with mood changes, but this is not a contraindication. 5

Non-Migrainous Headaches

  • Non-migrainous headaches are Category 1-2 for progestin-only methods. 1
  • Combined hormonal contraceptives would be Category 3-4 if these were migraines, but are already contraindicated due to hypertension. 1
  • Monitor for any change in headache pattern; new severe or persistent headaches require evaluation. 5

Common Pitfalls to Avoid

Do not prescribe combined hormonal contraceptives (pills, patches, rings) under any circumstances for this patient. 1, 2

Do not assume blood pressure will improve with weight loss alone—active pharmacologic management is required for poorly controlled hypertension. 1

Do not fail to assess smoking status—if currently smoking, intensive cessation counseling is mandatory as this is the most modifiable cardiovascular risk factor. 5, 3

Do not prescribe progestin-only methods without counseling about irregular bleeding patterns, which are common (not dangerous) and the most frequent reason for discontinuation. 5

Do not restart any form of combined hormonal contraceptive even if blood pressure becomes controlled—the multiple cardiovascular risk factors remain. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Contraception Guidelines for Women with Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cardiovascular risk and the use of oral contraceptives.

Neuro endocrinology letters, 2013

Guideline

Contraceptive Safety for Women with Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Contraceptive hormone use and cardiovascular disease.

Journal of the American College of Cardiology, 2009

Research

Oral contraceptives--induced hypertension--nine years later.

American journal of obstetrics and gynecology, 1976

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.